Literature DB >> 7732990

Coronary vascular reactivity is abnormal in patients with Chagas' heart disease.

F W Torres1, H Acquatella, J A Condado, R Dinsmore, I F Palacios.   

Abstract

Symptoms of myocardial ischemia, such as chest pain (sometimes with anginal features), acute myocardial infarction, and segmental wall motion abnormalities (including left ventricular apical aneurysm), frequently occur in patients with Chagas' heart disease. Because these clinical findings occur in the presence of normal coronary arteries, it is possible that an abnormality of the coronary vascular reactivity could be present in these patients. Therefore the current study was undertaken to determine whether endothelium-dependent coronary vasodilation is abnormal in Chagas' heart disease. Coronary endothelial function was assessed by infusing the endothelium-dependent vasodilator acetylcholine (10(-8) to 10(-6) mol/L) and the endothelium-independent vasodilator adenosine (10(-4) mol/L) into the left anterior descending coronary artery of nine patients (age 43 +/- 4 years) with Chagas' heart disease. Coronary blood flow was measured with a Doppler flow velocity catheter and by quantitative coronary cineangiography. The left ventricular ejection fraction was 39% +/- 5%; eight patients had a left ventricular apical aneurysm; and one had an area of anteroapical hypokinesis. An impairment of the endothelium-dependent coronary vasodilation was demonstrated by a reduction in coronary blood flow of 41.2% +/- 12.8% produced by the infusion of acetylcholine at 10(-6) mol/L and by a blunted but preserved increase in coronary blood flow of 114.6% +/- 65.0% with the infusion of adenosine at 10(-4) mol/L (p = 0.03). In conclusion, patients with Chagas' heart disease have an abnormality of the coronary endothelium-dependent vasodilation, and this abnormality may play a role in their chest pain syndrome and in the development of segmental wall motion abnormalities.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7732990     DOI: 10.1016/0002-8703(95)90122-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  12 in total

1.  Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells.

Authors:  Ghada S Hassan; Shankar Mukherjee; Fnu Nagajyothi; Louis M Weiss; Stefka B Petkova; Cecilia J de Almeida; Huan Huang; Mahalia S Desruisseaux; Boumediene Bouzahzah; Richard G Pestell; Chris Albanese; George J Christ; Michael P Lisanti; Herbert B Tanowitz
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 2.  The vasculature in chagas disease.

Authors:  Cibele M Prado; Linda A Jelicks; Louis M Weiss; Stephen M Factor; Herbert B Tanowitz; Marcos A Rossi
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

3.  Chagas heart disease: A contemporary review.

Authors:  Alejandro Velasco; Carlos A Morillo
Journal:  J Nucl Cardiol       Date:  2018-07-18       Impact factor: 5.952

Review 4.  Management of Cardiovascular Disease in Patients With COVID-19 and Chronic Chagas Disease: Implications to Prevent a Scourge Still Larger.

Authors:  Reinaldo Bulgarelli Bestetti; Edimar Alcides Bocchi; Renato Bestetti; Victor Sarli Issa; Rosemary Aparecida Furlan-Daniel; Marcelo Arruda Nakazone
Journal:  Front Med (Lausanne)       Date:  2022-06-29

Review 5.  Coronary microvascular disease in chronic Chagas cardiomyopathy including an overview on history, pathology, and other proposed pathogenic mechanisms.

Authors:  Marcos A Rossi; Herbert B Tanowitz; Lygia M Malvestio; Mara R Celes; Erica C Campos; Valdecir Blefari; Cibele M Prado
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31

6.  Coronary Microvascular Dysfunction: Does it Really Matter in Chagas Disease?

Authors:  Maria do Carmo Pereira Nunes
Journal:  Arq Bras Cardiol       Date:  2020-12       Impact factor: 2.000

7.  Alterations to the Cardiac Metabolome Induced by Chronic T. cruzi Infection Relate to the Degree of Cardiac Pathology.

Authors:  Kristyn Hoffman; Zongyuan Liu; Ekram Hossain; Maria Elena Bottazzi; Peter J Hotez; Kathryn M Jones; Laura-Isobel McCall
Journal:  ACS Infect Dis       Date:  2021-04-12       Impact factor: 5.578

8.  Mechanistic Insights into the Anti-angiogenic Activity of Trypanosoma cruzi Protein 21 and its Potential Impact on the Onset of Chagasic Cardiomyopathy.

Authors:  Samuel Cota Teixeira; Daiana Silva Lopes; Sarah Natalie Cirilo Gimenes; Thaise Lara Teixeira; Marcelo Santos da Silva; Rebecca Tavares E Silva Brígido; Felipe Andrés Cordero da Luz; Aline Alves da Silva; Makswell Almeida Silva; Pilar Veras Florentino; Paula Cristina Brígido Tavares; Marlus Alves Dos Santos; Veridiana de Melo Rodrigues Ávila; Marcelo José Barbosa Silva; Maria Carolina Elias; Renato Arruda Mortara; Claudio Vieira da Silva
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

Review 9.  Infectious myocarditis: the role of the cardiac vasculature.

Authors:  Linde Woudstra; Lynda J M Juffermans; Albert C van Rossum; Hans W M Niessen; Paul A J Krijnen
Journal:  Heart Fail Rev       Date:  2018-07       Impact factor: 4.214

10.  Echocardiographic and hemodynamic determinants of right coronary artery flow reserve and phasic flow pattern in advanced non-ischemic cardiomyopathy.

Authors:  Pedro Graziosi; Barbara Ianni; Expedito Ribeiro; Marco Perin; Leonardo Beck; Claudio Meneghetti; Charles Mady; Eulogio Martinez Filho; Jose A F Ramires
Journal:  Cardiovasc Ultrasound       Date:  2007-09-26       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.